REDD1 is required for RAS-mediated transformation of human ovarian epithelial cells

被引:53
作者
Chang, Bin [2 ,3 ]
Liu, Guangzhi
Yang, Gong
Mercado-Uribe, Imelda
Huang, Miao
Liu, Jinsong [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Unit 85, Houston, TX 77030 USA
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan, Hubei, Peoples R China
[3] Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China
基金
美国国家卫生研究院;
关键词
REDD1; RAS; ovarian cancer; transformation; anti-apoptosis; GENE-EXPRESSION; HYPOXIA; TUMORS; IDENTIFICATION; MUTATIONS; RTP801; PROTOONCOGENE; SUPPRESSION; STRESS; CANCER;
D O I
10.4161/cc.8.5.7887
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
REDD1 is a gene induced by hypoxia and stimuli from multiple DNA damage. Here we show that REDD1 expression was elevated in RAS-transformed ovarian epithelial cells lines and that this overexpression increased these cells' growth rate and anchorage-independent growth on soft agar. Injection of immortalized ovarian epithelial cells overexpressing REDD1 into nude mice resulted in tumor growth that developed into papillary serous carcinoma in the peritoneal cavity. Knockdown of REDD1 expression blocked the RAS-mediated transformation of these cell lines. REDD1 overexpression decreased apoptosis and associated with increased expression of Bcl-xL or Bcl-2 and decreased expression of FADD, caspase1, caspase8, caspase 9, caspase 10, BAX, Bad and Bcl-XS. Our data demonstrated that REDD1 is a key mediator in RAS-mediated transformation through an effect on anti-apoptosis.
引用
收藏
页码:780 / 786
页数:7
相关论文
共 25 条
  • [1] Multilineage embryonic hematopoiesis requires hypoxic ARNT activity
    Adelman, DM
    Maltepe, E
    Simon, MC
    [J]. GENES & DEVELOPMENT, 1999, 13 (19) : 2478 - 2483
  • [2] An SJ, 2005, BIOMED ENVIRON SCI, V18, P302
  • [3] Inhibition of oxygen-induced retinopathy in RTP801-deficient mice
    Brafman, A
    Mett, I
    Shafir, M
    Gottlieb, H
    Damari, G
    Gozlan-Kelner, S
    Vishnevskia-Dai, V
    Skaliter, R
    Einat, P
    Faerman, A
    Feinstein, E
    Shoshani, T
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (10) : 3796 - 3805
  • [4] Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
    Brugarolas, J
    Lei, K
    Hurley, RL
    Manning, BD
    Reiling, JH
    Hafen, E
    Witter, LA
    Ellisen, LW
    Kaelin, WG
    [J]. GENES & DEVELOPMENT, 2004, 18 (23) : 2893 - 2904
  • [5] Absence of full-length Brca1 sensitizes mice to oxidative stress and carcinogen-induced tumorigenesis in the esophagus and forestomach
    Cao, Liu
    Xu, Xiaoling
    Cao, Longyue L.
    Wang, Rui-Hong
    Coumoul, Xavier
    Kim, Sang S.
    Deng, Chu-Xia
    [J]. CARCINOGENESIS, 2007, 28 (07) : 1401 - 1407
  • [6] Cuatrecasas M, 1998, CANCER-AM CANCER SOC, V82, P1088
  • [7] Cuatrecasas M, 1997, CANCER, V79, P1581, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO
  • [8] 2-T
  • [9] Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling
    DeYoung, Maurice Phillip
    Horak, Peter
    Sofer, Avi
    Sgroi, Dennis
    Ellisen, Leif W.
    [J]. GENES & DEVELOPMENT, 2008, 22 (02) : 239 - 251
  • [10] REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species
    Ellisen, LW
    Ramsayer, KD
    Johannessen, CM
    Yang, A
    Beppu, H
    Minda, K
    Oliner, JD
    McKeon, F
    Haber, DA
    [J]. MOLECULAR CELL, 2002, 10 (05) : 995 - 1005